Innate Pharma S.A.

Good afternoon, ladies and gentlemen, and welcome to the Innate Farmers full year 2021 results conference call. At this time, all participants are in a listen-only mode. As a reminder, this conference call is being recorded. I will now hand over to Mr Henry Wheeler, Head of Investor Relations of Innate Farmer to begin. Sir, please go ahead.

Thank you. Good morning, good afternoon and welcome everyone. This morning Enate issued a press release providing a business update to the 2021 full year results. We look forward to presenting the progress made during the year to date as well as addressing future goals and milestones. The press release and today's presentation are both available on the IR section of the website. On slide two, I would like to remind you that we will make forward-looking statements regarding the financial outlook in addition to regulatory and product plan development. These statements are subject to risk and uncertainties that may cause actual results to differ from those forecasted. On slide three, on today's call, we will be joined by Monde Batumi, our chief executive officer, who will then hand over to Dr. Joyston Caracanel, our EVP .

Thank you Henry. Do you hear me well? I can hear you well now. Perfect, thank you.